BAYZF News and Press, Bayer AG Registered Shares From 04/16/24

2024-04-16 12:23:16 ET More on Bayer, Bayer AG, etc. Bayer AG (BAYZF) Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News (Rating Downgrade) Bayer: Long-Term Upside After The Dividend Cut Google, Bayer in pact fo...

2024-04-11 07:45:23 ET More on Ginkgo Bioworks Ginkgo Bioworks: Multiple Red Flags Ginkgo Bioworks: More Awful Revenue Guidance Ginkgo Bioworks Holdings, Inc. 2023 Q4 - Results - Earnings Call Presentation Ginkgo Bioworks expands R&D tie-up with Novo Nord...

2024-04-10 04:00:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...

2024-04-09 10:27:56 ET More on Bayer, Bayer AG, etc. ChatGPT Is An Existential Threat To Google Search's Ad-Based Model Google Is Still A Long-Term Buy Amid Its Gemini Troubles Google: Gemini Controversy Provides AI Opportunity Dynatrace expands partnership w...

2024-04-09 10:25:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...

2024-04-08 09:41:08 ET J.P.Morgan analysts published a list of European companies that would suffer due to higher financing costs. ... Read the full article on Seeking Alpha For further details see: European losers of higher financing costs - JPMorgan

2024-04-05 16:43:51 ET More on Bayer Bayer Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News Bayer: Long-Term Upside After The Dividend Cut Read the full article on Seeking Alpha For further details see...

2024-03-21 12:53:07 ET More on Boundless Bio, Inc. Boundless Bio Starts $100 Million U.S. IPO Plan IPO Roundup: Boundless Bio, NeOnc Technologies and more Oncology drug developer Boundless Bio files for $100M IPO Financial information for Boundless Bio, Inc. ...

2024-03-19 06:19:29 ET Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) said Tuesday it would seek marketing approval for its experimental menopause treatment, elinzanetant, after the drug was shown to reduce the frequency of hot flashes associated with menopause in a third late-stage trial......

2024-03-13 17:43:59 ET More on Bayer Bayer Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News Bayer: Long-Term Upside After The Dividend Cut Read the full article on Seeking Alpha For further details see...